A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers
出版年份 2014 全文链接
标题
A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers
作者
关键词
-
出版物
Molecular Oncology
Volume 8, Issue 8, Pages 1441-1457
出版商
Wiley
发表日期
2014-06-10
DOI
10.1016/j.molonc.2014.05.013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 17β-estradiol upregulates GREB1 and accelerates ovarian tumor progressionin vivo
- (2014) Laura A. Laviolette et al. INTERNATIONAL JOURNAL OF CANCER
- IQGAP1 Binds to Estrogen Receptor-α and Modulates Its Function
- (2014) Huseyin H. Erdemir et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence ofde novoor acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor
- (2013) Paul Vilquin et al. INTERNATIONAL JOURNAL OF CANCER
- Transcriptional Repression of Estrogen Receptor α Signaling by SENP2 in Breast Cancer Cells
- (2013) Thiziri Nait Achour et al. MOLECULAR ENDOCRINOLOGY
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer
- (2012) Rabia A. Gilani et al. BREAST CANCER RESEARCH AND TREATMENT
- ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial-Mesenchymal Transition and Invasion
- (2012) J. A. Vendrell et al. CANCER RESEARCH
- Activation of rapid oestrogen signalling in aggressive human breast cancers
- (2012) Coralie Poulard et al. EMBO Molecular Medicine
- GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer
- (2012) Mingli Liu et al. PLoS One
- The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression
- (2012) Laurie E. Littlepage et al. Cancer Discovery
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data
- (2011) Balázs Győrffy et al. BREAST CANCER RESEARCH AND TREATMENT
- St. Gallen 2011: Summary of the Consensus Discussion
- (2011) Michael Gnant et al. Breast Care
- Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
- (2011) Mohammed Tanjimur Rahman et al. CANCER
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- The ZNF217 oncogene is a candidate organizer of repressive histone modifiers
- (2010) Michaela S. Banck et al. Epigenetics
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
- (2010) Aurélie Thollet et al. Molecular Cancer
- CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer
- (2010) P. Plevova et al. NEOPLASMA
- ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells
- (2010) S R Krig et al. ONCOGENE
- Methylation, a key step for nongenomic estrogen signaling in breast tumors
- (2010) M. Le Romancer et al. STEROIDS
- A hypersensitive estrogen receptor α mutation that alters dynamic protein interactions
- (2009) Matthew H. Herynk et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells
- (2009) Peng Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
- (2009) Sandra E. Ghayad et al. INTERNATIONAL JOURNAL OF CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα
- (2009) K Akaogi et al. ONCOGENE
- Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
- (2008) Sherene Loi et al. BMC GENOMICS
- Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients
- (2008) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
- (2008) M. Chanrion et al. CLINICAL CANCER RESEARCH
- Genome Analysis Identifies the p15ink4b Tumor Suppressor as a Direct Target of the ZNF217/CoREST Complex
- (2008) G. Thillainadesan et al. MOLECULAR AND CELLULAR BIOLOGY
- Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity
- (2008) Robin Tharakan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase
- (2008) Krithika Subramanian et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started